Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats

This publication has 16 references indexed in Scilit:

• Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain
  Pain, 1995
• The clinically tested N-methyl-d-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy
  Neuroscience Letters, 1995
• The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats
  European Journal of Pharmacology, 1994
• Memantine selectively depresses NMDA receptor-mediated responses of rat spinal neurones in vivo
  Neuroscience Letters, 1994
• The NMDA antagonist memantine blocks pain behavior in a rat model of formalin-induced facial pain
  Pain, 1993
• Quantitative analysis of substance P and calcitonin gene-related peptide immunohistochemical staining in the dorsal horn of neuropathic MK-801-treated rats
  Brain Research, 1993
• An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
  Pain, 1992
• The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury
  Journal of Neuroscience, 1992
• Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels
  European Journal of Pharmacology, 1989
• Treatment of Impaired Cerebral Function in Psychogeriatric Patients with Memantine - Results of a Phase II Double-Blind Study
  Pharmacopsychiatry, 1988